UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 76 filers reported holding UTAH MED PRODS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,328,794 | +7.3% | 27,079 | +16.3% | 0.04% | +2.3% |
| Q2 2023 | $2,169,696 | +6.5% | 23,280 | +8.3% | 0.04% | +2.3% |
| Q1 2023 | $2,038,029 | +204.2% | 21,505 | +173.7% | 0.04% | +138.9% |
| Q3 2022 | $670,000 | -1.6% | 7,858 | -0.9% | 0.02% | +5.9% |
| Q2 2022 | $681,000 | -20.5% | 7,926 | -14.1% | 0.02% | -10.5% |
| Q3 2021 | $857,000 | +4.1% | 9,226 | -4.7% | 0.02% | +5.6% |
| Q2 2021 | $823,000 | +77.0% | 9,679 | +80.5% | 0.02% | +63.6% |
| Q1 2021 | $465,000 | +97.0% | 5,362 | +117.3% | 0.01% | +120.0% |
| Q2 2019 | $236,000 | -91.8% | 2,468 | -93.7% | 0.01% | -91.4% |
| Q3 2017 | $2,870,000 | +1.3% | 39,022 | -0.3% | 0.06% | +28.9% |
| Q2 2017 | $2,833,000 | +373.0% | 39,130 | +308.9% | 0.04% | +400.0% |
| Q1 2016 | $599,000 | -27.9% | 9,570 | -32.6% | 0.01% | -25.0% |
| Q4 2015 | $831,000 | – | 14,193 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 40,000 | $4,000,000 | 5.64% |
| Clean Yield Group | 14,474 | $1,447,000 | 0.46% |
| RICE HALL JAMES & ASSOCIATES, LLC | 113,833 | $11,383,000 | 0.40% |
| Ranger Investment Management | 68,730 | $6,873,000 | 0.38% |
| ISTHMUS PARTNERS, LLC | 17,534 | $1,753,000 | 0.29% |
| Cardinal Capital Management | 10,097 | $1,010,000 | 0.20% |
| GLOBEFLEX CAPITAL L P | 19,420 | $1,942,000 | 0.20% |
| Ancora Advisors LLC | 26,689 | $2,669,000 | 0.06% |
| Penobscot Investment Management Company, Inc. | 4,000 | $400,000 | 0.05% |
| SEIZERT CAPITAL PARTNERS, LLC | 10,430 | $1,043,000 | 0.05% |